Hyderabad: The BRS on Friday alleged that a serious financial fraud had taken place in the transfer of ownership rights of Leonia Resorts, saying Congress leader and former MP G. Ranjith Reddy was ...

LIC’s shareholding in Dr. Reddy’s Laboratories rose from 5.6% at the end of September 2024 to 6.5% by December 2024, and further to 7.19% as of March 2025, according to the latest shareholding ...

Dr Reddy’s Laboratories announced that it has partnered with Alvotech, to co-develop, manufacture, and sell a biosimilar version of Keytruda (pembrolizumab), for global markets.

Pharma major Dr. Reddy’s Laboratories and Nasdaq-listed global biotech firm Alvotech will co-develop, manufacture and commercialise a biosimilar candidate to Merck’s cancer drug Keytruda ...

CHENNAI: Shares of Dr Reddy’s Laboratories surged over 3% in early trade on Thursday after the Indian drug maker announced a global licensing agreement with Alvotech, an Iceland-based ...

Dr. Reddy launched generic Revlimid (multiple myeloma) in September 2022 or H2FY23. The US segment (45 per cent of FY25 sales) reported sales growth in FY22-25 of 24 per cent CAGR compared with 8 ...

Iceland based Biotech company Alvotech and Dr Reddy’s Laboratories have entered into a collaboration and license agreement to co-develop, manufacture and commercialise a biosimilar candidate to ...

Alvotech and Dr. Reddy's will share development, manufacturing, and commercialization responsibilities. Market-moving news hits Benzinga Pro first—get a 30-minute edge and save 60% this 4th of July.

On June 5, HSBC upgraded Dr. Reddy’s Laboratories Limited (NYSE:RDY) from Buy to Hold, raising the price target to INR1,445 from INR1,235, citing an optimistic outlook for the company in terms ...

In recent trading, shares of Dr. Reddy's Laboratories Ltd. (Symbol: RDY) have crossed above the average analyst 12-month target price of $15.40, changing hands for $15.53/share. When a stock ...

Shares of Dr. Reddy’s Laboratories surged 4 percent to Rs 1,303 on June 5, making it one of the top gainers on the Nifty 50. The rally followed the company’s announcement of a strategic ...

Shares of Dr. Reddy's Laboratories Ltd. 500124 advanced 2.32% to 1,349.90 Indian rupees Tuesday, on what proved to be an all-around poor trading session for the stock market, with the BSE SENSEX ...